294 related articles for article (PubMed ID: 15024700)
1. A truncated isoform of the PP2A B56gamma regulatory subunit reduces irradiation-induced Mdm2 phosphorylation and could contribute to metastatic melanoma cell radioresistance.
Koma YI; Ito A; Watabe K; Kimura SH; Kitamura Y
Histol Histopathol; 2004 Apr; 19(2):391-400. PubMed ID: 15024700
[TBL] [Abstract][Full Text] [Related]
2. A truncated isoform of the protein phosphatase 2A B56gamma regulatory subunit may promote genetic instability and cause tumor progression.
Ito A; Koma Y; Watabe K; Nagano T; Endo Y; Nojima H; Kitamura Y
Am J Pathol; 2003 Jan; 162(1):81-91. PubMed ID: 12507892
[TBL] [Abstract][Full Text] [Related]
3. Localization of the PP2A B56gamma regulatory subunit at the Golgi complex: possible role in vesicle transport and migration.
Ito A; Koma Y; Sohda M; Watabe K; Nagano T; Misumi Y; Nojima H; Kitamura Y
Am J Pathol; 2003 Feb; 162(2):479-89. PubMed ID: 12547706
[TBL] [Abstract][Full Text] [Related]
4. A truncated isoform of the PP2A B56 subunit promotes cell motility through paxillin phosphorylation.
Ito A; Kataoka TR; Watanabe M; Nishiyama K; Mazaki Y; Sabe H; Kitamura Y; Nojima H
EMBO J; 2000 Feb; 19(4):562-71. PubMed ID: 10675325
[TBL] [Abstract][Full Text] [Related]
5. A mutation in protein phosphatase type 2A as a cause of melanoma progression.
Ito A; Koma YI; Watabe K
Histol Histopathol; 2003 Oct; 18(4):1313-9. PubMed ID: 12973697
[TBL] [Abstract][Full Text] [Related]
6. Cyclin G recruits PP2A to dephosphorylate Mdm2.
Okamoto K; Li H; Jensen MR; Zhang T; Taya Y; Thorgeirsson SS; Prives C
Mol Cell; 2002 Apr; 9(4):761-71. PubMed ID: 11983168
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase 3-dependent phosphorylation of Mdm2 regulates p53 abundance.
Kulikov R; Boehme KA; Blattner C
Mol Cell Biol; 2005 Aug; 25(16):7170-80. PubMed ID: 16055726
[TBL] [Abstract][Full Text] [Related]
8. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
[TBL] [Abstract][Full Text] [Related]
9. SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival.
Fenouille N; Puissant A; Tichet M; Zimniak G; Abbe P; Mallavialle A; Rocchi S; Ortonne JP; Deckert M; Ballotti R; Tartare-Deckert S
Oncogene; 2011 Dec; 30(49):4887-900. PubMed ID: 21685937
[TBL] [Abstract][Full Text] [Related]
10. p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation.
Okada Y; Osada M; Kurata S; Sato S; Aisaki K; Kageyama Y; Kihara K; Ikawa Y; Katoh I
Exp Cell Res; 2002 Jun; 276(2):194-200. PubMed ID: 12027449
[TBL] [Abstract][Full Text] [Related]
11. Human lymphoblastoid cell lines expressing mutant p53 exhibit decreased sensitivity to cisplatin-induced cytotoxicity.
Piovesan B; Pennell N; Berinstein NL
Oncogene; 1998 Nov; 17(18):2339-50. PubMed ID: 9811465
[TBL] [Abstract][Full Text] [Related]
12. The p53-Mdm2 association in epithelial cells in idiopathic pulmonary fibrosis and non-specific interstitial pneumonia.
Nakashima N; Kuwano K; Maeyama T; Hagimoto N; Yoshimi M; Hamada N; Yamada M; Nakanishi Y
J Clin Pathol; 2005 Jun; 58(6):583-9. PubMed ID: 15917407
[TBL] [Abstract][Full Text] [Related]
13. The MDM2 oncoprotein promotes apoptosis in p53-deficient human medullary thyroid carcinoma cells.
Dilla T; Velasco JA; Medina DL; González-Palacios JF; Santisteban P
Endocrinology; 2000 Jan; 141(1):420-9. PubMed ID: 10614665
[TBL] [Abstract][Full Text] [Related]
14. Increased mdm-2 expression in a p53-independent manner blocks UV-induced cell cycle arrest and apoptosis in human osteosarcoma cells.
Dong YB; Yang HL; Elliott MJ; McMasters KM
Tumour Biol; 2003; 24(3):130-9. PubMed ID: 14610316
[TBL] [Abstract][Full Text] [Related]
15. Tissue and cell-specific expression of the p53-target genes: bax, fas, mdm2 and waf1/p21, before and following ionising irradiation in mice.
Bouvard V; Zaitchouk T; Vacher M; Duthu A; Canivet M; Choisy-Rossi C; Nieruchalski M; May E
Oncogene; 2000 Feb; 19(5):649-60. PubMed ID: 10698510
[TBL] [Abstract][Full Text] [Related]
16. Facilitation of adenoviral wild-type p53-induced apoptotic cell death by overexpression of p33(ING1) in T.Tn human esophageal carcinoma cells.
Shimada H; Liu TL; Ochiai T; Shimizu T; Haupt Y; Hamada H; Abe T; Oka M; Takiguchi M; Hiwasa T
Oncogene; 2002 Feb; 21(8):1208-16. PubMed ID: 11850840
[TBL] [Abstract][Full Text] [Related]
17. HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage.
Pääjärvi G; Roudier E; Crisby M; Högberg J; Stenius U
FASEB J; 2005 Mar; 19(3):476-8. PubMed ID: 15625077
[TBL] [Abstract][Full Text] [Related]
18. The MDM2 Inhibitor Navtemadlin Arrests Mouse Melanoma Growth
Ingelshed K; Spiegelberg D; Kannan P; Påvénius L; Hacheney J; Jiang L; Eisinger S; Lianoudaki D; Lama D; Castillo F; Bosdotter C; Kretzschmar WW; Al-Radi O; Fritz N; Villablanca EJ; Karlsson MCI; Wermeling F; Nestor M; Lane DP; Sedimbi SK
Cancer Res Commun; 2022 Sep; 2(9):1075-1088. PubMed ID: 36922937
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of p53 at serine 37 is important for transcriptional activity and regulation in response to DNA damage.
Dohoney KM; Guillerm C; Whiteford C; Elbi C; Lambert PF; Hager GL; Brady JN
Oncogene; 2004 Jan; 23(1):49-57. PubMed ID: 14712210
[TBL] [Abstract][Full Text] [Related]
20. mdm2 Is critical for inhibition of p53 during lymphopoiesis and the response to ionizing irradiation.
Mendrysa SM; McElwee MK; Michalowski J; O'Leary KA; Young KM; Perry ME
Mol Cell Biol; 2003 Jan; 23(2):462-72. PubMed ID: 12509446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
